Source archive
MEDVi: pricing source note
What we checked for MEDVi, when, and what we observed — so our figures are traceable.
| Provider | MEDVi |
|---|---|
| Source | MEDVi publicly available pricing |
| Date checked | June 2026 |
| Pricing observed | Dose-tiered: ~$279 introductory rising to ~$399–$499 at higher doses; oral and injectable options noted. Confirm what is bundled vs billed separately. |
| Change since last check | First recorded check — no prior snapshot to compare. Future checks will note changes here. |
We record what we observed from publicly available information on the date shown. We do not publish screenshots or store provider pages; figures are summarized in our own words and may change — verify current pricing directly. Compounded tirzepatide is not FDA-approved.
Found an error?
Help us stay accurate
If MEDVi's pricing has changed, submit a correction or, if you operate MEDVi, a provider update. We verify before changing any page.
Keep reading